Delivery Order SPE2DB22D1017-SPE2DB24FG5NF

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENOXAPARIN 80 MG/0.8 ML SYR 0.8ML syringes. The $1,150.68 firm fixed-price contract has an ultimate completion date of August 2, 2024. This delivery order is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal contracts to supply a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Enoxaparin 40 mg/0.4 ml syringes. The firm-fixed-price, delivery order contract has a ceiling value of $3,396.94 and a performance period ending on September 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables...
This contract award, valued at $1,534.68, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 100 mg/mL enoxaparin syringes, a critical anticoagulant medication used in military healthcare settings. The contract has an ultimate completion date of February 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,659.98 firm fixed-price delivery order is for the supply of 4566556101 - ENOXAPARIN 120 MG/0.8 ML SYR 0.8ML, a specialty medication. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,186.72, is for the delivery of Enoxaparin 80 mg/0.8 ml syringes. This is a firm-fixed-price delivery order with a completion date of January 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
This is a $1,135.68 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 150 mg/mL enoxaparin syringes, with a period of performance through May 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The order, valued at $1,026.42, is for the supply of ENOXAPARIN 100 MG/ML SYRINGEML, a specialty pharmaceutical product, in support of military treatment programs and facilities. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,215,870 units of the drug Enoxaparin 40 mg/0.4 ml syringe. The contract has a firm fixed price of $1,204.92 and an ultimate completion date of January 3, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,129.34, covers the supply of enoxaparin 120 mg/0.8 ml syringes. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a firm fixed price delivery order with the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Enoxaparin 150 mg/ml syringes. The award ceiling value is $1,999.73 and the ultimate completion date is March 27, 2024. The contract is not set aside for any specific business size or socioeconomic category. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG5NF
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,079.59 contract is for the delivery of ENOXAPARIN 100 MG/ML SYRINGEML, a critical specialty medication. It is a firm fixed-price delivery order, with an ultimate completion date of September 23, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/20/24, 9:20 AM